{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:33:03Z","timestamp":1781353983088,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.canrad.2025.104619","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:16:15Z","timestamp":1745435775000},"page":"104619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term outcomes of radiotherapy and impact of nodal disease burden in clinically node-positive prostate cancer"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-8790","authenticated-orcid":false,"given":"Tony","family":"Felefly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alborz","family":"Jooya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Laprade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyajit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2025.104619_bib0165","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1503\/cmaj.212097","article-title":"Projected estimates of cancer in Canada in 2022","volume":"194","author":"Brenner","year":"2022","journal-title":"CMAJ"},{"key":"10.1016\/j.canrad.2025.104619_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2025.104619_bib0175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clon.2019.04.012","article-title":"Who dies from prostate cancer? An analysis of the surveillance, epidemiology and end results database","volume":"31","author":"Roy","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2025.104619_bib0180","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104619_bib0185","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.canrad.2025.104619_bib0190","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Mottet","year":"2022"},{"key":"10.1016\/j.canrad.2025.104619_bib0195","series-title":"Prostate cancer (Version 4. 2022)","author":"National Comprehensive Cancer Network","year":"2022"},{"key":"10.1016\/j.canrad.2025.104619_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2019.05.016","article-title":"Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group","volume":"140","author":"Lieng","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0205","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ijrobp.2018.04.023","article-title":"Definitive radiation therapy and survival in clinically node-positive prostate cancer","volume":"101","author":"Bryant","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104619_bib0210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamaoncol.2015.4350","article-title":"Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial","volume":"2","author":"James","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0215","doi-asserted-by":"crossref","first-page":"djv119","DOI":"10.1093\/jnci\/djv119","article-title":"Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer","volume":"107","author":"Lin","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2025.104619_bib0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.prro.2012.11.011","article-title":"Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival","volume":"3","author":"Tward","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0225","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2014.01.008","article-title":"The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study","volume":"88","author":"Rusthoven","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104619_bib0230","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.eururo.2017.08.011","article-title":"Efficacy of local treatment in prostate cancer patients with clinically pelvic lymph node-positive disease at initial diagnosis","volume":"73","author":"Seisen","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2025.104619_bib0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.euo.2018.09.015","article-title":"Association between radical prostatectomy and survival in men with clinically node-positive prostate cancer","volume":"2","author":"Sarkar","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(21)02437-5","article-title":"Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol","volume":"399","author":"Attard","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.canrad.2025.104619_bib0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijrobp.2022.07.011","article-title":"Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a?","volume":"114","author":"Chopade","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104619_bib0250","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","article-title":"Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group","volume":"26","author":"Scher","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0255","series-title":"Zenodo","article-title":"Lifelines, survival analysis in Python","author":"Davidson-Pilon","year":"2022"},{"key":"10.1016\/j.canrad.2025.104619_bib0260","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.canrad.2025.104619_bib0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2025.104619_bib0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eururo.2016.07.043","article-title":"Patterns of lymph node failure after dose-escalated radiotherapy: implications for extended pelvic lymph node coverage","volume":"71","author":"Spratt","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2025.104619_bib0275","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG Oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104619_bib0280","doi-asserted-by":"crossref","first-page":"931.e1","DOI":"10.1016\/j.urolonc.2020.08.018","article-title":"The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: which patients are candidates for local therapy with radiation?","volume":"38","author":"Ieiri","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0285","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1002\/cam4.2985","article-title":"Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer","volume":"9","author":"Tsuchida","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.canrad.2025.104619_bib0290","doi-asserted-by":"crossref","first-page":"898774","DOI":"10.3389\/fonc.2022.898774","article-title":"Risk Factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer","volume":"12","author":"Spohn","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2025.104619_bib0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2008.05.023","article-title":"Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy","volume":"54","author":"Schumacher","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2025.104619_bib0300","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euf.2017.12.009","article-title":"The impact of lymph node metastases burden at radical prostatectomy","volume":"5","author":"Preisser","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.canrad.2025.104619_bib0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2025.104619_bib0310","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41391-021-00339-y","article-title":"Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer","volume":"24","author":"Morgan","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.canrad.2025.104619_bib0315","doi-asserted-by":"crossref","first-page":"e1003998","DOI":"10.1371\/journal.pmed.1003998","article-title":"Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: long-term results from the STAMPEDE randomised controlled trial","volume":"19","author":"Parker","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.canrad.2025.104619_bib0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11547-021-01435-8","article-title":"Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting","volume":"127","author":"Francolini","year":"2022","journal-title":"Radiol Med"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T14:37:14Z","timestamp":1747060634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1278321825000356"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104619","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of radiotherapy and impact of nodal disease burden in clinically node-positive prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104619"}}